Fecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant Recipients
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
The objective is to examine the effect of Fecal Microbiota Transplantation (FMT) compared
with vancomycin for cure of recurrent C. diff infection (CDI) in solid organ transplant (SOT)
recipients in a randomized, controlled clinical trial.
Phase:
Phase 2
Details
Lead Sponsor:
University of Wisconsin, Madison
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)